These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. High Patient Disease Burden in a Cross-sectional, Multicenter Contact Registry Study of Eosinophilic Gastrointestinal Diseases. Jensen ET; Aceves SS; Bonis PA; Bray K; Book W; Chehade M; Collins MH; Dellon ES; Falk GW; Gonsalves N; Gupta SK; Hirano I; Katzka DA; Kyle S; Mack D; Kodroff E; Leung J; Mukkada VA; Scott M; Paliana A; Sable K; Spergel JM; Strobel MJ; Krischer J; Rothenberg ME; Abonia P; J Pediatr Gastroenterol Nutr; 2020 Oct; 71(4):524-529. PubMed ID: 32541201 [TBL] [Abstract][Full Text] [Related]
27. Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders. Arakawa N; Yagi H; Shimizu M; Shigeta D; Shimizu A; Nomura S; Takizawa T; Yamada Y Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671497 [TBL] [Abstract][Full Text] [Related]
28. Eosinophilic Gastrointestinal Disorders Pathology. Collins MH; Capocelli K; Yang GY Front Med (Lausanne); 2017; 4():261. PubMed ID: 29379785 [TBL] [Abstract][Full Text] [Related]
29. Clinical Presentation of Patients with Eosinophilic Gastrointestinal Diseases beyond Eosinophilic Esophagitis. Papadopoulou A; Zevit N Immunol Allergy Clin North Am; 2024 May; 44(2):349-355. PubMed ID: 38575228 [TBL] [Abstract][Full Text] [Related]
30. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. Spergel JM; Book WM; Mays E; Song L; Shah SS; Talley NJ; Bonis PA J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):300-6. PubMed ID: 21057327 [TBL] [Abstract][Full Text] [Related]
31. Elements Involved In Promoting Eosinophilic Gastrointestinal Disorders. Shukla A; Mishra A; Venkateshaiah SU; Manohar M; Mahadevappa CP; Mishra A J Genet Syndr Gene Ther; 2015 Aug; 6(2):. PubMed ID: 27840774 [TBL] [Abstract][Full Text] [Related]
33. Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease. Kuang FL; De Melo MS; Makiya M; Kumar S; Brown T; Wetzler L; Ware JM; Khoury P; Collins MH; Quezado M; Pittaluga S; Klion AD J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1598-1605.e2. PubMed ID: 35283330 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of Eosinophilic Gastroenteritis and Colitis in a Population-Based Study, From 2012 to 2017. Mansoor E; Saleh MA; Cooper GS Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1733-1741. PubMed ID: 28603057 [TBL] [Abstract][Full Text] [Related]
35. The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs. Ridolo E; Barone A; Ottoni M; Peveri S; Montagni M; Nicoletta F Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338983 [TBL] [Abstract][Full Text] [Related]
38. Eosinophilic Esophagitis Patients Are Not at Increased Risk of Severe COVID-19: A Report From a Global Registry. Zevit N; Chehade M; Leung J; Marderfeld L; Dellon ES J Allergy Clin Immunol Pract; 2022 Jan; 10(1):143-149.e9. PubMed ID: 34688963 [TBL] [Abstract][Full Text] [Related]
39. Eosinophilic gastroenteritis and related eosinophilic disorders. Prussin C Gastroenterol Clin North Am; 2014 Jun; 43(2):317-27. PubMed ID: 24813518 [TBL] [Abstract][Full Text] [Related]